OX40/OX40L downregulators (Genentech/Xenova)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameOX40/OX40L downregulators (Genentech/Xenova)
Drug Alias NameOX40-IgG fusion protein (Xenova)OX40-hIgG4mut fusion protein (Xenova)OX40 immunoglobulin fusion proteins (Xenova)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 inhibitorsTumor necrosis factor ligand superfamily member 4 inhibitors
TargetsTumor necrosis factor ligand superfamily member 4Tumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCantab BiopharmaceuticalsXenova Group LtdStanford University +[4] 
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A